September 17, 2012
UC San Diego Moores Cancer Center launched a bold plan today, aimed at personalizing cancer treatment. The “My Answer to Cancer” team of oncologists, bioinformaticians, pathologists and geneticists pledges to “sequence” or analyze the DNA of large numbers of patients with cancer in order to match each patient to the…
February 27, 2018
…human metabolism. Researchers used the tool to map disease-related mutations on proteins and also probed how genes and proteins change in response to certain drugs. The work provides a better understanding of disease-causing mutations and could enable researchers to discover new uses for existing drug treatments.
September 25, 2013
A team of cancer researchers at the University of California, San Diego has identified the existence of precursor cells in early prostate cancers. These cells are resistant to androgen-deprivation therapy, and may drive the subsequent emergence of recurrent or metastatic prostate cancer.
May 25, 2014
Researchers at the University of California, San Diego School of Medicine have identified a mutated gene common to adenosquamous carcinoma (ASC) tumors – the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
February 18, 2015
Scientists at the University of California, San Diego School of Medicine have found that mutations that cause autism in children are connected to a pathway that regulates brain development.
January 29, 2015
…tumor that accounts for roughly 3 percent of all cancers in the United States.
July 2, 2019
Bladder cancer, one of the most common cancers in the U.S., may be soon helped by a novel non-invasive diagnostic method thanks to machine learning research by researchers at UC San Diego’s San Diego Supercomputer Center and Moores Cancer Center.
December 8, 2020
Compared to chimpanzees, our closest evolutionary cousins, humans are particularly prone to developing advanced carcinomas — the type of tumors that include prostate, breast, lung and colorectal cancers — even in the absence of known risk factors, such as genetic predisposition or tobacco use.
October 13, 2021
UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies have failed.
March 25, 2024
Engineering professors Ludmil Alexandrov and Sheng Xu were inducted into the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE), one of the highest distinctions accorded to medical and biological engineers.
